Serum β2 microglobulin (β2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients

Keitaro Yokoyama, H. Yoshida, N. Matsuo, Y. Maruyama, Y. Kawamura, R. Yamamoto, K. Hanaoka, M. Ikeda, H. Yamamoto, M. Nakayama, Y. Kawaguchi, T. Hosoya

研究成果: Article査読

27 被引用数 (Scopus)

抄録

Background: Encapsulating peritoneal sclerosis (EPS) is a serious complication in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD). The aim of this study was to find a predictor for EPS. Methods: Patients with EPS who were detected by a historical cohort study using clinical data of 219 CAPD patients at our hospital. We recruited 25 patients with EPS who were compared with the patients without EPS who were matched for age and dialysis period as controls. Differences between the two groups (non-EPS group and EPS group) with respect to age, gender, primary disease, dialysis period, serum urea nitrogen, serum creatinine, β2MG, CRP and PET (peritoneal equilibration test) category (determined by the peritoneal function testing) were analyzed. Results: According to multiple regression analysis, a high β 2MG level was an independent risk factor for EPS (odds ratio 1.162, 95% confidence interval 1.026 - 1.317, p = 0.018). Other clinical markers did not show positive significance. A ROC (receiver operating characteristic) curve was prepared to evaluate the suitability of β2MG measurement as a screening test. The sensitivity was 64% and the specificity was 80% when a β2MG level of 37.0 mg/dl was taken as the cut-off value. The odds ratio for occurrence of EPS was 8.8 when β2MG level was in the range of 35 -40 mg/dl, 13.5 when β2MG level was > 40 mg/dl and 1 when β2MG level was < 30 mg/dl. Conclusion: These findings suggest that β2MG is useful as a screening test for the onset of EPS, and that β2MG and accumulation of middle-molecular uremic substances may be related to the pathophysiology of EPS.

本文言語English
ページ(範囲)121-126
ページ数6
ジャーナルClinical nephrology
69
2
DOI
出版ステータスPublished - 2008 2月

ASJC Scopus subject areas

  • 腎臓病学

フィンガープリント

「Serum β2 microglobulin (β2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル